BIOVICCA
ActiveFrom the official registers: KBO 13 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
For BIOVICCA, one filing cycle of the annual accounts is missing. The 2024 annual accounts show equity of €28,772 and a net result of €5,154. Equity is growing by about 3.2% per year across the filed financial years. Its solvency ranks better than 58% of 9,457 sector peers (NACE 82, financial year 2024). The company has been active since 2011 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 1.0% (low).
History
Acts, filings and financial milestones
2025
04-02
financial year 2024 · micro format · 4 days late
2024
30-06
Financial
Weakest financial yearnet €5,154 ▼27.3%
Net result drops to €5,154, the lowest in the series.
11-01
financial year 2023 · micro format
2023
02-02
financial year 2022 · micro format · 2 days late
2022
03-01
financial year 2021 · micro format
2021
16-02
financial year 2020 · micro format · 16 days late
2020
30-06
Financial
Highest result from 2019 to 2024net €45,862 ▲2%
Operating result €75,032, net result €45,862, both a record.
30-06
Financial
Liquidity more than doubledcurrent ratio 2.06
Current ratio from 0.89 to 2.06; short-term debt falls from €37,794 to €27,892.
16-01
financial year 2019 · micro format
2019
15-01
financial year 2018 · micro format
2018
05-01
financial year 2017 · micro format
2017
16-01
financial year 2016 · abbreviated format
2016
14-03
financial year 2015 · abbreviated format · 43 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank